Gabriella Ferrandina, Franco Oreste Ranelletti, Giovanni Scambia, Pierluigi Benedetti Panici, Giuseppe D'Agostino, Mauro Piantelli, Giulio Isola & Salvatore Mancuso. (1995) Interaction of tamoxifen with cytosolic and nuclear Type II estrogen binding sites (Type II EBS). Cancer Letters 96:1, pages 123-131.
Crossref
Luigi M. Larocca, Mario Giustacchini, Nicola Maggiano, Franco O. Ranelletti, Mauro Piantelli, Eugenio Alcini & Arnaldo Capelli. (1994) Growth-Inhibitory Effect of Quercetin and Presence of Type II Estrogen Binding Sites in Primary Human Transitional Cell Carcinomas. The Journal of Urology 152:3, pages 1029-1033.
Crossref
Anthony A. Colletta, Fiona V. Howell & Michael Baum. (1989) A novel binding site for a synthetic progestagen in breast cancer cells. Journal of Steroid Biochemistry 33:6, pages 1055-1061.
Crossref
Charles L. Densmore, Barry M. Markaverich, Bert W. O'Malley & James H. Clark. (2002) Characterization and partial purification of an estrogen type II binding site in chick oviduct cytosol. Biochemistry 28:19, pages 7788-7796.
Crossref
M. Yu, J. Cates, I. Leav & S.-M. Ho. (1989) Heterogeneity of [3H]estradiol binding sites in the rat prostate: Properties and distribution of type I and type II sites. Journal of Steroid Biochemistry 33:3, pages 449-457.
Crossref
János Garai, Marietta Vértes & Sándor Kovács. (1989) In vitro effects of cytosolic inhibitor and opiates on the binding of [3H]oestradiol to nuclear type II binding sites of rat uterus and hypothalamus. Journal of Steroid Biochemistry 32:3, pages 433-438.
Crossref
Barry M. Markaverich, Brian S. Middleditch & James Clark. 1989. Gene Regulation by Steroid Hormones IV. Gene Regulation by Steroid Hormones IV
213
219
.
G. Turcotte, A. Chapdelaine & S. Chevalier. (1988) Multiple binding components for methyltrienolone in canine prostatic epithelial cells. Journal of Steroid Biochemistry 31:6, pages 955-962.
Crossref
B M Markaverich, R R Gregory, M A Alejandro, J H Clark, G A Johnson & B S Middleditch. (1988) Methyl p-hydroxyphenyllactate. An inhibitor of cell growth and proliferation and an endogenous ligand for nuclear type-II binding sites.. Journal of Biological Chemistry 263:15, pages 7203-7210.
Crossref
Èva Lànyi, József Szèkely & Marietta Vértes. (1988) The effect of prostaglandin F2α treatment on the endometrial oestradiol receptor system. Prostaglandins, Leukotrienes and Essential Fatty Acids 31:1, pages 27-30.
Crossref
Barry M. Markaverich, Rebecca R. Roberts, Mary A. Alejandro, Gregory A. Johnson, Brian S. Middleditch & James H. Clark. (1988) Bioflavonoid interaction with rat uterine type ii binding sites and cell growth inhibition. Journal of Steroid Biochemistry 30:1-6, pages 71-78.
Crossref
Barry M. Markaverich, N.R. Adams, Rebecca R. Roberts, Mary Alejandro & James H. Clark. (1987) Cytosol type II sites in the rat uterus: Interaction with an endogenous ligand. Journal of Steroid Biochemistry 28:6, pages 599-608.
Crossref
M.T.P. Lopes, M.H. Liberato, A. Widman & M.M. Brentani. (1987) Occupied and unoccupied type II estrogen binding sites in human breast cancer. Journal of Steroid Biochemistry 26:2, pages 219-226.
Crossref
B. M. Markaverich & J. H. Clark. 1987. Gene Regulation by Steroid Hormones III. Gene Regulation by Steroid Hormones III
50
65
.
Daniel M. Sheehan, Kevin L. Medlock & C. Richard Lyttle. (1986) Identification of uterine nuclear type II estrogen binding sites in estrogen treated rats. Journal of Steroid Biochemistry 25:1, pages 37-43.
Crossref
Reid W. McNaught & Roy G. Smith. (2002) Characterization of a second estrogen receptor species in chick oviduct. Biochemistry 25:8, pages 2073-2081.
Crossref
Akio Matsuzawa. 1986.
303
340
.
James H. Clark & Barry M. Markaverich. 1986. Steroid Hormone Resistance. Steroid Hormone Resistance
305
315
.
Barry M. Markaverich & James H. Clark. 1985. Molecular Mechanism of Steroid Hormone Action. Molecular Mechanism of Steroid Hormone Action
399
412
.
A L Lin & S A Shain. (1985) Estrogen-mediated cytoplasmic and nuclear distribution of rat cardiovascular estrogen receptors.. Arteriosclerosis: An Official Journal of the American Heart Association, Inc. 5:6, pages 668-677.
Crossref
J.H. Clark, R.C. Winneker & B.M. Markaverich. 1985. Biochemical Actions of Hormones. Biochemical Actions of Hormones
353
383
.
Louis P. Pertschuk, Karen B. Eisenberg, Richard J. Macchia & Joseph G. Feldman. (2006) Heterogeneity of steroid binding sites in prostatic carcinoma: Morphological demonstration and clinical implications. The Prostate 6:1, pages 35-47.
Crossref
James H. Clark & Barry M. Markaverich. (1984) The agonistic and antagonistic actions of estriol. Journal of Steroid Biochemistry 20:4, pages 1005-1013.
Crossref
C R Lyttle, K L Medlock & D M Sheehan. (1984) Eosinophils as the source of uterine nuclear type II estrogen binding sites.. Journal of Biological Chemistry 259:5, pages 2697-2700.
Crossref
A. Danguy, G. Leclercq & J. C. Heuson. 1984. Clinical Interest of Steroid Hormone Receptors in Breast Cancer. Clinical Interest of Steroid Hormone Receptors in Breast Cancer
68
74
.
B M Markaverich, R R Roberts, R W Finney & J H Clark. (1983) Preliminary characterization of an endogenous inhibitor of [3H]estradiol binding in rat uterine nuclei.. Journal of Biological Chemistry 258:19, pages 11663-11671.
Crossref
J. H. Clark, C. S. Watson, B. M. Markaverich, J. S. Syne & W. B. Panko. (1983) Heterogeneity of estrogen binding sites in mammary tumors. Breast Cancer Research and Treatment 3:1, pages 61-65.
Crossref
James H. Clark & Barry M. Markaverich. (1983) The agonistic and antagonistic effects of short acting estrogens: A review. Pharmacology & Therapeutics 21:3, pages 429-453.
Crossref
B. M. Markaverich & J. H. Clark. 1983. Gene Regulation by Steroid Hormones II. Gene Regulation by Steroid Hormones II
219
238
.
George E. Swaneck, Juan M. Alvarez & Gerald Sufrin. (1982) Multiple species of estrogen binding sites in the nuclear fraction of the rat prostate. Biochemical and Biophysical Research Communications 106:4, pages 1441-1447.
Crossref
Walter B. Panko, Cheryl S. Watson & James H. Clark. (1981) The presence of a second, specific estrogen binding site in human breast cancer. Journal of Steroid Biochemistry 14:12, pages 1311-1316.
Crossref
G.E. Alonso, J.A. Burdman & I. Szijan. (1981) Studies on estrogen receptors in the cytosol and nuclei of the rat anterior pituitary gland. Determination of specific sites by [3H]-estradiol exchange assay. Journal of Steroid Biochemistry 14:12, pages 1285-1291.
Crossref
Walter B. Panko & James H. Clark. (1981) The effects of a second specific estrogen binding site on estrogen receptor quantitation in human breast cancer cytosol. Journal of Steroid Biochemistry 15, pages 383-386.
Crossref
Barry M. Markaverich & James H. Clark. (1981) Quantitation of nuclear-estrogen receptors in the rat uterus by [3H]-estradiol exchange. Journal of Steroid Biochemistry 15, pages 289-292.
Crossref
James H. Clark & Barry M. Markaverich. (1981) Relationships between type I and II estradiol binding sites and estrogen induced responses. Journal of Steroid Biochemistry 15, pages 49-54.
Crossref
Barry M. Markaverich, Susan Upchurch & J.H. Clark. (1981) Progesterone and dexamethasone antagonism of uterine growth: A role for a second nuclear binding site for estradiol in estrogen action. Journal of Steroid Biochemistry 14:2, pages 125-132.
Crossref
George E. Swaneck, Juan M. Alvarez & Gerald Sufrin. 1981. Cellular Responses to Molecular Modulators. Cellular Responses to Molecular Modulators
550
.
H. GELBARD, D. U'PRICHARD & P. STERN. 1981. Steroid Hormone Regulation of the Brain. Steroid Hormone Regulation of the Brain
265
276
.